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Abstract
Background: Failure in the timely follow-up of test results has been widely documented, contributing to delayed
medical care. Yet, the impact of delay in reviewing test results on hospital length of stay (LOS) has not been
studied. We examine the relationship between laboratory tests review time and hospital LOS.
Methods: A retrospective cohort study of inpatients admitted to a metropolitan teaching hospital in Sydney,
Australia, between 2011 and 2012 (n = 5804). Generalized linear models were developed to examine the
relationship between hospital LOS and cumulative clinician read time (CRT), defined as the time taken by clinicians
to review laboratory test results performed during an inpatient stay after they were reported in the computerized
test reporting system. The models were adjusted for patients’ age, sex, and disease severity (measured by the
Charlson Comorbidity index), the number of test panels performed, the number of unreviewed tests pre-discharge,
and the cumulative laboratory turnaround time (LTAT) of tests performed during an inpatient stay.
Results: Cumulative CRT is significantly associated with prolonged LOS, with each day of delay in reviewing test
results increasing the likelihood of prolonged LOS by 13.2% (p < 0.0001). Restricting the analysis to tests with
abnormal results strengthened the relationship between cumulative CRT and prolonged LOS, with each day of
delay in reviewing test results increasing the likelihood of delayed discharge by 33.6% (p < 0.0001). Increasing age,
disease severity and total number of tests were also significantly associated with prolonged LOS. Increasing number
of unreviewed tests was negatively associated with prolonged LOS.
Conclusions: Reducing unnecessary hospital LOS has become a critical health policy goal as healthcare costs
escalate. Preventing delay in reviewing test results represents an important opportunity to address potentially
avoidable hospital stays and unnecessary resource utilization.
Keywords: Length of stay, Test results, Delay
Background
Inpatient hospital services constitute almost one-third of
all health care expenditures in the United States [1].
Substantial research and policy efforts have been
directed at reducing unnecessary hospital length of stay
(LOS), a key indicator for inpatient resource use. Re-
search into the determinants of hospital length of stay
(LOS) has identified a range of patient characteristics
and clinical predictors contributing to prolonged LOS
[2]. These include age, sex, disease severity, presenting
conditions and complications [3–10]. While useful in
guiding resource planning, most patient and disease-
specific variables are not amenable to interventions that
would reduce unnecessary hospital stays.
More often than not, hospital LOS is also driven by
institutional factors unrelated to individual patients’
conditions, such as clinical workflow and hospital
resources. Patients may experience prolonged hospitali-
zations due to delays in accessing care [11]. Identifying
these modifiable factors can provide important oppor-
tunities for interventions.
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Here, we conduct the first study to explore the rela-
tionship between laboratory tests review time and LOS.
Because clinical laboratory testing is an integral part of
healthcare delivery, driving a large proportion of critical
medical decisions, we hypothesize that delay in review-
ing test results prolongs hospital LOS.
Methods
Settings and participants
This study was conducted at a 370-bed metropolitan
teaching hospital. A hospital-wide computerized system
was in place for reporting all diagnostic tests. The
system captured detailed information on the time and
date when laboratory tests were requested, when the
results were available for review, and when they were
viewed by the providers. Participants included all inpa-
tients admitted to the hospital between February 2011
and February 2012. Clinical pathology tests performed
were extracted from the computerized test-reporting
system; these included clinical chemistry, clinical
pharmacology, hematology, immunology and microbiol-
ogy. Tests relating to arterial blood gases were excluded,
since the results for these tests were communicated
directly to the ordering physician. We further extracted
from the hospital admission database the admission
details of the patients, including date of admission and
discharge, principal diagnosis (expressed as free text),
and the department where inpatient care was provided.
This study was approved by the Human Research Ethics
Committee at the University of New South Wales (Syd-
ney, Australia), with patient consent waived.
Study outcomes
The primary outcome of interest was the relationship
between hospital LOS and clinician read time (CRT),
defined as the time taken by a provider to access labora-
tory test results after they were available for review in
the test reporting system (Fig. 1). The provider who
reviewed the test results may be the ordering provider
or any members of the healthcare team. Since
patients often underwent multiple tests, we calculated
the cumulative CRT for all tests performed during an
inpatient stay.
Timeliness in reviewing test results is dependent on
timely processing of laboratory tests. The impact of
laboratory turnaround time (LTAT), defined as the time
between ordering of test and when the test results are
available for review, has been reported to prolong LOS
in high-volume patient care settings such as the emer-
gency department. We therefore assessed the modifying
effect of LTAT on the relationship between CRT and
hospital LOS, and compare the effects of CRT and LTAT
on hospital LOS. We hypothesize that cumulative CRT
is independently associated with prolonged hospital
LOS.
Statistical analysis
Descriptive statistics were used to quantify the preva-
lence of baseline characteristics, including patient demo-
graphics, inpatient medical specialties, the time of day
tests were ordered, processed and reviewed. The impact
of CRT on LOS was evaluated using generalized linear
models. We used the gamma family of distributions to
account for skewness in the distribution of LOS, with
logarithm as the link function. We included in the
model patients’ age, sex, and disease severity (measured
by the Charlson Comorbidity index), the total number of
test panels performed during the inpatient stay, and the
cumulative LTAT. We further controlled for the number
of tests that were not reviewed during the inpatient stay,
since tests that were not followed up were unlikely to
prolong hospital LOS. An additional sensitivity analysis
was performed that excluded patients with tests that
were not followed up during an inpatient stay. To com-
pare the impact of delay in reviewing abnormal test
results and normal test results, we conducted a sensitiv-
ity analysis that considered only tests with abnormal
findings, and a separate analysis that included only
normal test results. With the exception of sex, all vari-
ables were modeled as continuous variables. The
resulting estimated coefficients are presented as back-
transformed (exponentiated), which are interpretable
as the multiplicative effects of predictor variables on
the expected LOS.
To address potential reverse causation in the associ-
ation between CRT and LOS, whereby prolonged LOS
causes delay in CRT, we assessed variability in the
Fig. 1 Laboratory tests processing and review workflow
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follow-up behavior of providers throughout inpatient
stays, by quantifying the average CRT for tests ordered
on each day of hospital admission, from day one to day
14 of admission. We observed that tests ordered on the
first 2 days of admission had an average CRT of 26 and
21 h, respectively (Additional file 1: Figure S1). The aver-
age CRT for tests ordered on subsequent days (i.e. day
three to 14 of admission) was about 12 h and did not
vary with prolonged LOS. To account for this pattern,
we conducted an additional sensitivity analysis where
CRT was measured based only on tests ordered in the
first 48 h of admission, and a further analysis that quan-
tified CRT based on tests ordered after the first 48 h of
admission among patients who were hospitalized for two
or more days.
Analyses were conducted using R statistical software
version 3.4.3. All tests of statistical significance were
two-tailed and used an α level of p < 0.05.
Subgroup analyses
Clinical workflow and resources may differ across de-
partments within the hospital, which may alter the
relationship between CRT and hospital LOS. To assess if
the effect of CRT on hospital LOS was consistently
observed across different medical departments, we per-
formed subgroup analyses for four of the departments
with the largest number of inpatient admissions during
the study period: geriatrics, cardiology, general surgery,
and psychiatry. Separate models were developed for each
department to assess the relationship between cumula-
tive CRT and LOS. To account for potential confound-
ing associated with patient heterogeneity, we further
performed additional subgroup analyses that considered
inpatients with the same principal admitting diagnosis.
Two subgroups were selected a priori: patients with
renal failure and patients who underwent elective knee
or hip replacement surgery; the former represents a
group of critically ill patients requiring urgent care, and
the latter represents a more routine and non-urgent
patient population. We hypothesize that the impact of
CRT on LOS was greater among the renal failure popu-
lation, compared with patients who were admitted for
an elective knee or hip replacement surgery.
Results
A total of 5804 inpatient admissions satisfied the inclu-
sion criteria (Table 1). The mean and median LOS were
7.5 and 4 days, respectively. The distribution of LOS is
illustrated in Fig. 2a. On average, 7.2 test panels were
performed during an inpatient stay, with a median of 4
test panels per inpatient stay. An inpatient experienced a
mean cumulative CRT of 1.6 days, and a cumulative
LTAT of 2.5 days. The average CRT and LTAT for
Table 1 Study participants (n = 5804)
Attributes N (%)
Age
< = 30 140 (2.4)
31 to 64 2530 (43.6)
> = 65 3134 (54.0)
Sex (female) 2481 (42.7)
Charlson comorbidity index
0 3508 (60.4)
1 897 (15.5)
2 649 (11.2)
3 318 (5.5)
> = 4 432 (7.4)
Patients with one or more unreviewed tests, n (%) 3129 (53.9)
Department, n (%)
Geriatrics 983 (16.9)
Cardiology 765 (13.2)
General surgery 554 (9.5)
Psychiatry 396 (6.8)
Respiratory medicine 388 (6.7)
Orthopedic surgery 354 (6.1)
Neurology 237 (4.1)
Gastroenterology 217 (3.7)
Vascular surgery 155 (2.7)
Neurosurgery 150 (2.6)
Hematology 147 (2.5)
Urology 144 (2.5)
Cardiothoracic surgery 108 (1.9)
Nephrology 102 (1.8)
Dermatology 75 (1.3)
Rehabilitation 68 (1.2)
Otolaryngology 62 (1.1)
Palliative care 57 (1.0)
Drug and alcohol 53 (0.9)
Immunology 50 (0.9)
Infectious diseases 49 (0.8)
Endocrinology 32 (0.6)
Oncology 29 (0.5)
Obstetrics and gynecology 23 (0.4)
Rheumatology 23 (0.4)
Maxillofacial surgery 6 (0.1)
Dental surgery 2 (0.03)
Radiation oncology 2 (0.03)
Ophthalmology 1 (0.02)
Unspecified 572 (9.9)
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individual tests was 12.7 h and 16.1 h, respectively; the
median CRT and LTAT for individual tests was an hour.
Cumulative CRT is significantly associated with
prolonged LOS, with each day of delay in reviewing test
results increasing the likelihood of prolonged hospital
stay by 13.2% (p < 0.0001). Increasing age, disease sever-
ity and total number of tests were also significantly asso-
ciated with prolonged LOS (Table 2a). Patient’s sex was
not associated with LOS in univariate analysis, and was
therefore excluded from the multivariate models. While
cumulative LTAT was significantly associated with LOS
in univariate analysis, its effect on LOS became insignifi-
cant in the multivariate generalized linear model. In-
creasing number of unreviewed tests was negatively
associated with prolonged LOS.
A total of 3129 (53.9%) patients had one or more test
results that were not followed up during hospitalization.
Excluding these patients from the analysis strengthened
the impact of cumulative CRT on prolonged LOS, with
each day of delay in reviewing test results increasing the
likelihood of delayed discharge by 18.6% (p < 0.0001). In
this subpopulation, increasing age and disease severity
were not associated with prolonged LOS; increasing
number of test panels and cumulative LTAT were associ-
ated with prolonged LOS (Table 2b).
Of the laboratory tests ordered, 30.4% had abnormal re-
sults. Including only tests with abnormal results in the
analysis strengthened the relationship between cumulative
CRT and prolonged LOS, with each day of delay in review-
ing test results increasing the likelihood of delayed dis-
charge by 33.6% (p < 0.0001), compared with 12.2% (p < 0.
0001) when only tests with normal results were consid-
ered (Table 2c, d). In the two sensitivity analyses that
quantified delay based on tests ordered within the first
48 h of admission and tests ordered after the first 48 h of
admission, respectively, cumulative CRT remained a
significant predictor of LOS (p < 0.0001) (Table 2e, f ).
Subgroup analyses
The effect of cumulative CRT on prolonged LOS was
consistently observed across different departments (geri-
atrics, cardiology, general surgery and psychiatry) and
patient subgroups with varying principal diagnoses
(renal failure, knee or hip replacement) (Table 3).
Fig. 2 Distribution of hospital length of stay (LOS) and patterns of test ordering, processing and review
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Table 2 Generalized linear model for predicting hospital LOS
Covariate Estimate (β) (95% CI) p-value
(a) Primary analysis including all inpatients
Age 1.003 (1.001–1.005) < 0.0001
Charlson comorbidity index 1.020 (1.004–1.037) 0.017
Number of test panels 1.054 (1.048–1.060) < 0.0001
Cumulative CRT (days) 1.132 (1.116–1.149) < 0.0001
Cumulative LTAT (days) 0.996 (0.988–1.004) 0.165
Number of unreviewed tests 0.988 (0.985–0.992) < 0.0001
(b) Sensitivity analysis including only patients without any unreviewed
tests
Age 1.001 (0.999–1.004) 0.267
Charlson comorbidity index 1.019 (0.989–1.051) 0.247
Number of test panels 1.060 (1.047–1.073) < 0.0001
Cumulative CRT (days) 1.186 (1.154–1.221) < 0.0001
Cumulative LTAT (days) 1.028 (1.004–1.054) 0.022
(c) Sensitivity analysis including only laboratory tests with abnormal results
Age 1.001 (0.999–1.002) 0.381
Charlson comorbidity index 1.020 (1.004–1.037) 0.022
Number of test panels 1.073 (1.065–1.081) < 0.0001
Cumulative CRT (days) 1.336 (1.294–1.380) < 0.0001
Cumulative LTAT (days) 1.010 (0.993–1.029) 0.231
Number of unreviewed tests 0.971 (0.958–0.984) < 0.0001
(d) Sensitivity analysis including only laboratory tests with normal results
Age 1.003 (1.001–1.004) 0.002
Charlson comorbidity index 1.019 (1.003–1.036) 0.026
Number of test panels 1.063 (1.056–1.070) < 0.0001
Cumulative CRT (days) 1.122 (1.105–1.139) < 0.0001
Cumulative LTAT (days) 0.990 (0.982–0.999) 0.002
Number of unreviewed tests 0.984 (0.980–0.988) < 0.0001
(e) Sensitivity analysis including only tests ordered in the first two days
of admission
Age 1.003 (1.001–1.005) 0.002
Charlson comorbidity index 1.018 (1.001–1.037) 0.057
Number of test panels 1.065 (1.058–1.072) < 0.0001
Cumulative CRT (days) 1.030 (1.017–1.044) < 0.0001
Cumulative LTAT (days) 1.017 (1.008–1.027) < 0.0001
Number of unreviewed tests 0.987 (0.983–0.991) < 0.0001
(f) Sensitivity analysis excluding tests ordered in the first two days of
admission
Age 1.001 (1.000–1.003) 0.159
Charlson comorbidity index 0.999 (0.984–1.013) 0.855
Number of test panels 1.025 (1.020–1.031) < 0.0001
Cumulative CRT (days) 1.055 (1.046–1.064) < 0.0001
Cumulative LTAT (days) 0.990 (0.983–0.997) 0.001
Number of unreviewed tests 0.989 (0.986–0.992) < 0.0001
Table 3 Subgroup analyses by department and principal
diagnoses
Covariate Estimate (β) (95% CI) p-value
(a) Department: geriatric medicine
Age 0.998 (0.991–1.005) 0.516
Charlson comorbidity index 0.992 (0.957–1.029) 0.661
Number of test panels 1.072 (1.060–1.085) < 0.0001
Cumulative CRT (days) 1.108 (1.080–1.137) < 0.0001
Cumulative LTAT (days) 0.995 (0.972–1.018) 0.652
Number of unreviewed tests 0.996 (0.990–1.003) 0.274
(b) Department: cardiology medicine
Age 1.001 (0.998–1.004) 0.467
Charlson comorbidity index 1.049 (1.018–1.083) 0.002
Number of test panels 1.112 (1.099–1.126) < 0.0001
Cumulative CRT (days) 1.049 (1.012–1.092) 0.001
Cumulative LTAT (days) 0.979 (0.962–0.998) 0.003
Number of unreviewed tests 0.999 (0.993–1.006) 0.829
(c) Department: general surgery
Age 1.003 (0.999–1.006) 0.123
Charlson comorbidity index 1.019 (0.986–1.056) 0.283
Number of test panels 1.114 (1.097–1.132) < 0.0001
Cumulative CRT (days) 1.034 (1.000–1.076) 0.026
Cumulative LTAT (days) 0.975 (0.944–1.008) 0.133
Number of unreviewed tests 0.992 (0.986–0.998) 0.012
(d) Department: psychiatry
Age 1.011 (1.000–1.023) 0.054
Charlson comorbidity index 1.060 (0.951–1.212) 0.368
Number of test panels 1.168 (1.080–1.270) < 0.0001
Cumulative CRT (days) 1.140 (1.077–1.213) < 0.0001
Cumulative LTAT (days) 1.048 (0.995–1.112) 0.031
Number of unreviewed tests 0.959 (0.942–0.981) 0.0002
(e) Principal diagnosis: renal failure
Age 1.007 (0.995–1.019) 0.289
Charlson comorbidity index 0.921 (0.841–1.013) 0.087
Number of test panels 1.037 (0.995–1.080) 0.090
Cumulative CRT (days) 1.182 (1.092–1.289) 0.0002
Cumulative LTAT (days) 1.006 (0.966–1.050) 0.776
Number of unreviewed tests 0.994 (0.977–1.013) 0.509
(f) Principal diagnosis: knee or hip replacement surgery
Age 1.004 (0.994–1.014) 0.404
Charlson comorbidity index 1.025 (0.848–1.265) 0.815
Number of test panels 1.054 (1.016–1.095) 0.007
Cumulative CRT (days) 1.177 (1.071–1.299) 0.003
Cumulative LTAT (days) 1.004 (0.905–1.116) 0.941
Number of unreviewed tests 0.992 (0.978–1.008) 0.335
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Increasing number of tests performed during inpatient
stay was also consistently associated with prolonged
LOS. The relationship between prolonged LOS and the
remaining covariates were variably observed across
departments and principal diagnoses.
Clinical workflow
The majority of inpatient laboratory tests were ordered
between 6 am and 12 pm (Fig. 2b), and most test results
were available for review between 8 am and 2 pm (Fig. 2c).
Review of test results followed the same trend, peaking
between 9 am and 3 pm (Fig. 2d).
Figure 3 depicts the relationship between the time of
day a laboratory test was placed, and the average CRT
and LTAT, considering only tests that were reviewed
during the inpatient stay. Both CRT and LTAT appeared
to peak at around 2 pm, where the average total time
taken to process and review a test was 23.7 h after a test
was ordered. Comparing the CRT and LTAT of la-
boratory tests ordered before and after 2 pm, those
that were placed after 2 pm experienced a much
greater total delay (18.0 h vs 12.4 h; p < 0.0001), with
both a greater CRT (7.5 vs 5.2 h; p < 0.0001) and
LTAT (10.1 vs 6.8 h; p < 0.0001).
Discussion
We established for the first time that delay in reviewing
laboratory test results is significantly associated with
prolonged hospital LOS. Delay in reviewing test results
may prevent timely diagnosis and treatment, resulting in
suboptimal outcomes that may further contribute to
prolonged LOS. In our study, only one-third of test
results had abnormal findings. Thus, in most cases, delay
in test results follow-up was unlikely to affect health
outcomes. However, our analysis shows that delay in
reviewing normal test results is also a significant
predictor of prolonged hospitalization. Patients may re-
main hospitalized while awaiting their test results to be
reviewed before a discharge decision can be made. Redu-
cing test review delay therefore represents an important
opportunity to address potentially avoidable hospital
stays and unnecessary resource utilization.
Turnaround time for laboratory tests did not appear
to affect hospital LOS in the primary analysis that
included all inpatients. A probable explanation is that a
large proportion of laboratory tests were not actually
reviewed prior to patient discharge [12] – delay in pro-
cessing these tests were therefore unlikely to influence
LOS. Indeed, the number of unreviewed tests was found
to be negatively associated with LOS. In the secondary
analysis that considered only patients who had their test
results reviewed during their inpatient stay, a significant
relationship between increasing cumulative LTAT and
prolonged LOS was observed. However, the strength of
the association was notably weaker than the association
between delay in reviewing test results and LOS. The
effects of LTAT on LOS have been extensively studied,
primarily in the emergency care setting [13]. While a
number of studies demonstrated a significant relation-
ship between LTAT and LOS, others have failed to show
the benefit of reducing LTAT on LOS [14, 15]. Substan-
tial efforts to improve the efficiency of pathology work-
flow has significantly reduced the delay associated with
laboratory turnaround time. However, delay in reviewing
test results has received much less attention. Our ana-
lysis suggests that unless test results are reviewed in a
timely manner, any benefits gained from reducing LTAT
will be greatly diminished.
The time of day laboratory tests were ordered, proc-
essed and reviewed followed similar trends, increasing in
volume during late mornings and early afternoons, and
tapering off during late-afternoon (Fig. 2b-d). This likely
reflects the window of time whereby the bulk of routine
clinical decision-making took place. We further observed
that the average CRT and LTAT for individual tests
varied by the time of day the tests were ordered, peaking
at around 2 pm, coinciding with the time with the high-
est volume of tests ordered (Fig. 3). The high load of
laboratory tests may have caused the delay in turn-
around time, and as a result, laboratory tests that were
ordered after 2 pm had a substantially longer delay in
CRT and LTAT. These findings strongly suggest that
clinical workflow and available resources played an
important role in influencing when test results were
processed and reviewed. Improving workflow and re-
source allocation may therefore offer an opportunity to
reduce unnecessary hospital stay. For example, enhan-
cing capacity planning to address variability in staffing
workload, such as increasing resources during peak pe-
riods [16], and reviewing test results when they are
Fig. 3 The relationship between hour of day tests were ordered,
and the laboratory turnaround time (LTAT), clinician read time (CRT),
and the total time (LTAT + CRT)
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available and discharging patients when they are clinic-
ally ready for discharge, regardless of the time of day,
may improve patient flow and reduce unnecessary LOS.
There are also potential opportunities for leveraging
health informatics technology to facilitate the timely
notification of available test results to providers more
quickly. Any such interventions would need to ensure
that providers are not unduly burdened with alarm
fatigue and additional workload, and that the interven-
tions do not lead to other unintended consequences.
Study limitations
Our study is limited to a single center. Other centers
may vary greatly in resources and organizational struc-
ture, which may in turn influence the relationship be-
tween delay in reviewing test results and LOS.
Nonetheless, we believe that the organization of care in
this teaching hospital is similar to other hospitals in
most developed countries. To address the potential bias
caused by variability in clinical workflow, we performed
subgroup analyses of departments that served vastly dif-
ferent patient subpopulations within the hospital, includ-
ing geriatrics, general surgery, cardiology and psychiatry.
Additionally, subgroup analyses that considered patients
with different principal diagnosis were conducted. The
relationship between delay in test results follow-up and
LOS was consistently observed in these analyses. Indeed,
cumulative CRT and the number of tests performed
were the only variables that were significantly associated
with LOS across all settings and patient populations.
Our study cannot establish causality. While we have
included potential confounders in our models, including
disease severity and patient’s age, we could not account
for other important factors such as staffing level, team
rotations, and the behavior of individual providers –
these factors can lead to delay in test results follow-up
and directly impact the quality of care that results in
prolonged hospitalization independent of delay in test
results follow-up. Providers may also be less inclined to
rapidly review test results if they expect patients to
remain hospitalized due to their conditions. However,
our analysis of the follow-up behavior of test results by
day of admission suggests that on average, the overall
test results follow-up patterns were not driven by the
expected LOS. Furthermore, in sensitivity analyses that
considered separately tests ordered within the first 2
days of admission and tests ordered after the first 2 days
of admission, the association between delay in test re-
sults follow-up and LOS remained significant.
There is also limitation in the use of Charlson comor-
bidity index to adjust for disease severity, an important
determinant of LOS. While Charlson comorbidity index
– a weighted score of comorbidities based on their rela-
tive risk of mortality – has been extensively validated in
published literature as a reliable prognostic indicator for
mortality [17–20], its predictive power may vary across
different patient subpopulations. To address this limita-
tion, we conducted additional subgroup analyses for
patients who were likely to have similar disease severity
based on their principal reason for admission, including
patients with renal failure and those who were admitted
for an elective hip or knee replacement. In all analyses,
the relationship between test follow-up delay and pro-
longed LOS was consistently observed. While further re-
search is needed to understand the relationship between
delay in reviewing test results and LOS and to account
for unmeasured confounders, our unique data source
that captures fine-grained timestamps of when tests
were ordered, processed and reviewed, offer the rare
opportunity to quantify delay in test results follow-up
and to study its impact on LOS.
Conclusions
Reducing unnecessary hospital LOS has become a crit-
ical health policy goal as the costs of healthcare escalate,
and budgetary constraints in health care limit available
resources. Our study highlights an important, yet under-
explored, risk factor of prolonged LOS that warrants
further investigation. Preventing delay in reviewing test
results may provide a low-hanging fruit for ameliorating
unnecessary hospital stays.
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